Liraglutide Promotes Osteoblastic Differentiation in MC3T3-E1 Cells by ERK5 Pathway

Liraglutide is a glucagon-like peptide-1 analogue widely used in the treatment of type 2 diabetes mellitus. However, the effects of liraglutide on osteoblast proliferation and differentiation in MC3T3-E1 cells have not been fully elucidated. In the present study, the promoting effects of liraglutide...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yue, Liang, Yuzhen, Li, Zhengming, Xia, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780226/
https://www.ncbi.nlm.nih.gov/pubmed/33488706
http://dx.doi.org/10.1155/2020/8821077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780226/
https://www.ncbi.nlm.nih.gov/pubmed/33488706
http://dx.doi.org/10.1155/2020/8821077

Ejemplares similares